• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Development of multiplex Nucleic Acid Sequence-Based Amplification for detection of human respiratory tract viruses

tetano

Editor, Senior Moderator
J Virol Methods. 2010 May 3. [Epub ahead of print]
Development of multiplex Nucleic Acid Sequence-Based Amplification for detection of human respiratory tract viruses.

Lau LT, Feng XY, Lam TY, Hui HK, Yu AC.

Neuroscience Research Institute; Department of Neurobiology, School of Basic Medical Sciences; the Key Laboratory for Neuroscience (Ministry of Education); the Key Laboratory for Neuroscience (Ministry of Public Health); Peking University, Beijing, China; Beijing Hai Kang DNA Chips Limited, Beijing Economic Development Area, Yizhuang, Beijing, China; Infectious Disease Center, Peking University, Beijing, China; Hai Kang Life Corporation Limited, Shau Kei Wan, Hong Kong SAR, China.
Abstract

A group of common lower respiratory tract infections, influenza A, influenza B, human parainfluenza virus 1-4 (HPIV1-4), respiratory syncytial virus (RSV), rubella virus (RV) and Coxsackie virus (CSV), were selected for the development of a multiplex Nucleic Acid Sequence-Based Amplification (NASBA) assay. Quantifiable measurement utilizing an emzyme-linked oligonucleotide capture (EOC) optical detection method, which was described previously, alleviated the requirement of specialized instrumentation that is commonly used in other molecular techniques. Multiplex NASBA-EOC provided rapid and specific detection of a single virus from a multiplexed group, reducing laboratory testing time and enabling high throughput screening. The uniquely designed primers and probes proved to be highly sensitive and specific, exemplifying the robustness of the multiplex NASBA-EOC technique. Copyright ? 2010. Published by Elsevier B.V.

PMID: 20447419 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20447419?dopt=Abstract
 
Back
Top